These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3410487)

  • 1. The toxic oil syndrome in Spain. Was it due to a combined action of trichothecene mycotoxins and of inhibitors of carboxyesterase?
    Schoental R
    Hum Toxicol; 1988 Jul; 7(4):365-6. PubMed ID: 3410487
    [No Abstract]   [Full Text] [Related]  

  • 2. Seminar on cardiovascular manifestations of the toxic oil syndrome and related conditions.
    Bruschke AV; James TN
    J Am Coll Cardiol; 1991 Sep; 18(3):707-10. PubMed ID: 1869733
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?
    Philen RM; Hill RH
    Mayo Clin Proc; 1993 Feb; 68(2):197-200. PubMed ID: 8423703
    [No Abstract]   [Full Text] [Related]  

  • 4. The association of oil ingestion with toxic oil syndrome in two convents.
    Diaz de Rojas F; Castro García M; Abaitua Borda I; Alonso Gordo JM; Posada de la Paz M; Kilbourne EM; Tabuenca Oliver JM
    Am J Epidemiol; 1987 May; 125(5):907-11. PubMed ID: 3565366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of the toxic oil syndrome.
    Philen RM; Posada de la Paz M; Hill RH; Schurz HH; Abaitua Borda I; Gómez de la Cámara A; Kilbourne EM
    Arch Toxicol Suppl; 1997; 19():41-52. PubMed ID: 9079193
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
    Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and isolation of pentachlorophenol in oil samples associated with the Spanish toxic oil syndrome.
    Guitart R; Abián J; Arboix M; Gelpí E
    Bull Environ Contam Toxicol; 1990 Aug; 45(2):181-8. PubMed ID: 2400832
    [No Abstract]   [Full Text] [Related]  

  • 8. Analytical measurements of products of aniline and triglycerides in oil samples associated with the toxic oil syndrome.
    Schurz HH; Hill RH; Philen RM; Posada de la Paz M; Abaitua Borda I; Kilbourne EM; Bernert T; Needham LL
    Arch Toxicol Suppl; 1997; 19():53-64. PubMed ID: 9079194
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic oil syndrome.
    Beranek JT
    Am Heart J; 1991 Dec; 122(6):1792-3. PubMed ID: 1957784
    [No Abstract]   [Full Text] [Related]  

  • 10. Oil ingestion and the toxic-oil syndrome: results of a survey of residents of the Orcasur neighbourhood in Madrid, Spain.
    Cañas R; Kilbourne EM
    Int J Epidemiol; 1987 Mar; 16(1):3-6. PubMed ID: 3570618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic oil syndrome.
    Fitzpatrick KC
    Am Heart J; 1992 Jun; 123(6):1722-3. PubMed ID: 1595563
    [No Abstract]   [Full Text] [Related]  

  • 12. The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.
    Hertzman PA
    Adv Exp Med Biol; 1996; 398():339-42. PubMed ID: 8906286
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxic oil syndrome and Paracetamol].
    Posada de la Paz M
    Aten Primaria; 2002 Mar; 29(4):258-60. PubMed ID: 11893309
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous mucinosis in the toxic oil syndrome.
    Fonseca E; Contreras F
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):139-40. PubMed ID: 3805384
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicologists versus toxicological disasters: toxic oil syndrome, clinical aspects.
    Gómez de la Cámara A; Abaitua Borda I; Posada de la Paz M
    Arch Toxicol Suppl; 1997; 19():31-40. PubMed ID: 9079192
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological aspects of the toxic oil syndrome.
    Lahoz C; del Pozo V; Gallardo S; Cárdaba B; Jurado A; Cortegano I; del Amo A; Arrieta I; Palomino P
    Arch Toxicol Suppl; 1997; 19():65-73. PubMed ID: 9079195
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol.
    Hill RH; Schurz HH; Posada de la Paz M; Abaitua Borda I; Philen RM; Kilbourne EM; Head SL; Bailey SL; Driskell WJ; Barr JR
    Arch Environ Contam Toxicol; 1995 Feb; 28(2):259-64. PubMed ID: 7710294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in patients with eosinophilia-myalgia syndrome or toxic oil syndrome.
    Cheng TO
    Mayo Clin Proc; 1993 Aug; 68(8):823-4. PubMed ID: 8331987
    [No Abstract]   [Full Text] [Related]  

  • 19. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM
    Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.